Pediatric AML: Gemtuzumab ozogamicin prior to allo-HCT increases risk for veno-occlusive diseaseMay 7, 2021AML
Hematology NewsPediatric cancer survivors at risk for opioid misuseMay 5, 2021ALLPatient & Survivor CareOpioid Resource CenterPediatricsCNS/Brain CancerLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Hematology NewsMitochondrial DNA predicts survival in pediatric acute myeloid leukemiaApril 23, 2021AMLPediatricsLeukemia, Myelodysplasia, Transplantation
Hematology NewsPredicting outcomes in therapy-related AMLApril 22, 2021AMLTransplantLeukemia, Myelodysplasia, Transplantation
